Navigation Links
LifeCare Holdings, Inc. Announces Third Quarter Results
Date:11/14/2007

expense of approximately $1.9 million.

The interest rates per annum applicable to loans, other than swingline loans, under our senior secured credit facility are, at our option, equal to either an alternate base rate or an adjusted LIBOR rate for a one-, two-, three- or six-month interest period, or a nine- or twelve-month period if available, in each case, plus an applicable margin. The applicable margins on the loans as amended are currently (1) 2.25% for alternate base rate revolving loans, (2) 3.25% for adjusted LIBOR revolving loans, (3) 2.25% for alternate base rate term loans, and (4) 3.25% for adjusted LIBOR term loans. These margins are subject to reduction based upon the ratio of our total indebtedness to our consolidated adjusted EBITDA (as defined in the credit agreement governing our senior secured credit facility and Amendment Number 1 to the credit agreement). At September 30, 2007, the interest rate applicable to the $249.9 million under our term loan facility was 8.20%.

As of September 30, 2007 we were not in compliance with the financial covenant requirements as set forth in the credit agreement for the Facility. However, this event of non-compliance was cured on November 14, 2007 through the exercise of a cure right as provided for in the credit agreement. The cure right provides us the right to issue permitted cure securities in exchange for cash or otherwise receive cash that would be contributed to our capital in an amount that is necessary to satisfy the financial covenant requirement on a pro-forma basis. The cure right capital contribution amount is considered additional consolidated EBITDA, as defined in our credit agreement, for purposes of measuring compliance with the financial covenants for our fiscal quarter ended September 30, 2007. In subsequent periods, this cure amount will continue to be considered a component of consolidated EBITDA on a trailing four-quarter calculation basis. Additionally, the cure amount is limited
'/>"/>

SOURCE LifeCare Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
2. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
5. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
6. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
7. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
8. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
9. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
10. China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2008)...ge, MA...Free prescription drug samples distribute...by physicians from Cambridge Health Alliance and H... first to look at free drug sample use among child...ics . , The authors, who also serve as research...t Medical School of Brown University, found that c...
(Date:10/5/2008)...ss. (October 6, 2008) Asthmatic children whose pa...function normally are less likely to have symptoms...ccording to a new study. Children also are more li...ately if they have a routine for taking medicine a...mptoms can be controlled. , The study, which app...
(Date:10/3/2008)...ties, the corner store, with its chips, soda and c...od residents, but also researchers are discovering... Researchers from Temple University and The Food ... children before and after school as part of a lar... Their findings will be presented at The Obesity S...
(Date:10/3/2008)...a Joins Nationwide Komen Community Challenge Campa...lier for Low-Income Women and Women of .../PRNewswire/ -- Pennsylvania House Speaker Dennis,...d breast cancer survivors,and advocates from the P...re(R) at a public forum this morning to call for p...
Breaking Medicine News(10 mins):Health News:Free drug samples carry risks for children 2Health News:Children's asthma affected by parental expectations 2Health News:Corner stores capture kids on morning commute 2Health News:Susan G. Komen for the Cure(R), Speaker Dennis O'Brien, Obama and McCain Health Care Advisors, Breast Cancer Survivors and Advocates Call for Needed Health Care Reforms 2Health News:Susan G. Komen for the Cure(R), Speaker Dennis O'Brien, Obama and McCain Health Care Advisors, Breast Cancer Survivors and Advocates Call for Needed Health Care Reforms 3
...more than humor and ridicule, researchers say they... the role of laughter during psychotherapy. Curren...ing emotion than about humor. Researchers videotap...ogical measurements of both members of 10 patient-...
...olescent girls estrogen treatments to keep them fr...oblems later on in life . Estrogen is thought to l... study involved 780 women who had been assessed fo...d a fertility survey later in life. About half had...
...can successfully treat metabolic syndrome in most ...abolic syndrome is a combination of conditions put... disease. The syndrome is characterized by higher ...l, high blood pressure, and obesity. The study inv...
...0 are affected by Parkinson’s disease. The conditi...ity, and tremors. Patients also suffer from loss o...already being used to treat the symptoms of Parkin...ts progression say researchers . The drug, pramip...
Other Medicine News:
(Date:10/2/2008)...harmaleads has obtained from the,French Medicine A...gle,ascending dose Phase I study with PL37, its le...., Neuropathic pain is a major chronic pain condi...population of up to 6%, according to the most,rece...pes, diabetes,antiviral or antitumor chemotherapy...
(Date:10/2/2008)...rstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; ...sed on,endocrine therapy and oncology, today repor...t recruitment for its Phase 2 trial in ovarian can... hormone (LHRH) agonist,linked to doxorubicin. The...ruitment was taken following recent first stage da...
(Date:10/1/2008)... of Amylin,s integrated neurohormonal ...GO, Oct. 1 /- Amylin Pharma...hat new data for its pipeline obesity,candidates w...ting of The,Obesity Society in Phoenix October 3-7...he largest and most comprehensive scientific confe...
(Date:10/1/2008)...unoVaccine Technologies, (IVT),patented depot vacc...re-clinical results, with single-dose efficacy ach... disease vaccine models. The results of this,resea...I conference in,Germany. Collaborators from the Un...pabilities of IVT,s depot formulations for deliver...
Breaking Medicine Technology:Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases 2New book further supports controversial theory of Man the Hunted 4547 1New book further supports controversial theory of Man the Hunted 4547 2New book further supports controversial theory of Man the Hunted 4547 3New book further supports controversial theory of Man the Hunted 4547 4New book further supports controversial theory of Man the Hunted 4547 5Service and Hardware Revenues Will Contribute 241 8 Billion to the U S Eldercare Industry by 2013 25612 1Service and Hardware Revenues Will Contribute 241 8 Billion to the U S Eldercare Industry by 2013 25612 2New insights into the regulation of PTEN tumor suppression function 4545 1New insights into the regulation of PTEN tumor suppression function 4545 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 4543 1Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 4543 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 4543 3
...e to Advance Clinical and Regulatory Development o...May 22, 2007 /PRNewswire-FirstCall/ -- Celgene,Cor...pment of,leading oral anti-inflammatory candidates...-10004 (apremilast), an oral TNF,antagonist and an...,activity and an excellent side effect profile in ...
...RN, Pa., May 22, 2007 /PRNewswire-FirstCall/ -- Au...new data show,improvements in symptoms of decrease...6 percent of hypogonadal men after switching,brand...estosterone,levels increased significantly in pati...osterone gel) following suboptimal,response to Sol...
Other Medicine Technology:Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort.
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
It's easy on delicate urethral tissues. The gentle, silicone design and hydrophilic coating provide nearly friction-free movement, without a lubricating gel. It's easy to maintain sterility. You simp
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
Medicine Products: